INS and obesity due to melanocortin 4 receptor deficiency: This strategy mitigates various obesity-induced effects, including a reduction in body weight, improvement in insulin sensitivity, insulin resistance, glucose tolerance, systemic inflammation, restoration of circadian rhythm, and amelioration of memory deficits [27,28,29,30,31].